share_log

BRIEF-Halozyme Reports Proposed Offering Of $500 Mln Of Convertible Senior Notes Due 2027

BRIEF-Halozyme Reports Proposed Offering Of $500 Mln Of Convertible Senior Notes Due 2027

Brief-Halozyme报告提议发售5亿美元2027年到期的可转换优先票据
路透社 ·  2021/02/24 05:36

Feb 23 (Reuters) - Halozyme Therapeutics Inc :
   * HALOZYME THERAPEUTICS, INC. ANNOUNCES PROPOSED OFFERING OF $500 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027
   * HALOZYME THERAPEUTICS - INTENDS TO OFFER, SUBJECT TO MARKET CONDITIONS AND OTHER FACTORS, $500 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

路透2月23日电-Halozyme治疗公司：*Halozyme治疗公司宣布拟发售5亿美元2027年到期的可转换优先票据*Halozyme Treeutics-打算根据市场状况和其他因素，发售2027年到期的5亿美元可转换优先票据Eikon的源文本：进一步的公司报道：(Reurs.Briefs@thomsonreurs.com；)

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发